Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2011 Jan 01;791:42-50. doi: 10.1124/mol.110.066928.
Show Gene links
Show Anatomy links
Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel.
Bhave G
,
Chauder BA
,
Liu W
,
Dawson ES
,
Kadakia R
,
Nguyen TT
,
Lewis LM
,
Meiler J
,
Weaver CD
,
Satlin LM
,
Lindsley CW
,
Denton JS
.
???displayArticle.abstract???
The renal outer medullary potassium (K+) channel, ROMK (Kir1.1), is a putative drug target for a novel class of loop diuretic that would lower blood volume and pressure without causing hypokalemia. However, the lack of selective ROMK inhibitors has hindered efforts to assess its therapeutic potential. In a high-throughput screen for small-molecule modulators of ROMK, we previously identified a potent and moderately selective ROMK antagonist, 7,13-bis(4-nitrobenzyl)-1,4,10-trioxa-7,13-diazacyclopentadecane (VU590), that also inhibits Kir7.1. Because ROMK and Kir7.1 are coexpressed in the nephron, VU590 is not a good probe of ROMK function in the kidney. Here we describe the development of the structurally related inhibitor 2,2'-oxybis(methylene)bis(5-nitro-1H-benzo[d]imidazole) (VU591), which is as potent as VU590 but is selective for ROMK over Kir7.1 and more than 65 other potential off-targets. VU591 seems to block the intracellular pore of the channel. The development of VU591 may enable studies to explore the viability of ROMK as a diuretic target.
BARTTER,
Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.
1962, Pubmed
BARTTER,
Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.
1962,
Pubmed
Bhave,
Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.
2010,
Pubmed
Carrisoza-Gaytán,
Potassium secretion by voltage-gated potassium channel Kv1.3 in the rat kidney.
2010,
Pubmed
Chuang,
Regulation of IRK3 inward rectifier K+ channel by m1 acetylcholine receptor and intracellular magnesium.
1997,
Pubmed
,
Xenbase
Clark,
Unique natriuretic properties of the ATP-sensitive K(+)-channel blocker glyburide in conscious rats.
1993,
Pubmed
Fallen,
The Kir channel immunoglobulin domain is essential for Kir1.1 (ROMK) thermodynamic stability, trafficking and gating.
2009,
Pubmed
Grimm,
BK channels in the kidney.
2007,
Pubmed
Grobbee,
Non-potassium-sparing diuretics and risk of sudden cardiac death.
1995,
Pubmed
Hebert,
Molecular diversity and regulation of renal potassium channels.
2005,
Pubmed
Ho,
Cloning and expression of an inwardly rectifying ATP-regulated potassium channel.
1993,
Pubmed
,
Xenbase
Jain,
Morphological similarity: a 3D molecular similarity method correlated with protein-ligand recognition.
2000,
Pubmed
Ji,
Rare independent mutations in renal salt handling genes contribute to blood pressure variation.
2008,
Pubmed
Jiang,
Endogenous Kv channels in human embryonic kidney (HEK-293) cells.
2002,
Pubmed
Lewis,
High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1.
2009,
Pubmed
Lu,
ROMK is required for expression of the 70-pS K channel in the thick ascending limb.
2004,
Pubmed
Macdonald,
What is the optimal serum potassium level in cardiovascular patients?
2004,
Pubmed
Milligan,
Robotic multiwell planar patch-clamp for native and primary mammalian cells.
2009,
Pubmed
Ookata,
Localization of inward rectifier potassium channel Kir7.1 in the basolateral membrane of distal nephron and collecting duct.
2000,
Pubmed
Peters,
Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.
2002,
Pubmed
Pluznick,
Renal fluid and electrolyte handling in BKCa-beta1-/- mice.
2003,
Pubmed
Rieg,
The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion.
2007,
Pubmed
Simon,
Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK.
1996,
Pubmed
Tobin,
Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population.
2008,
Pubmed
Wang,
Effects of a novel KATP channel blocker on renal tubule function and K channel activity.
1995,
Pubmed
Wang,
Effects of glyburide on renal tubule transport and potassium-channel activity.
1995,
Pubmed
Wang,
Effect of arachidonic acid on activity of the apical K+ channel in the thick ascending limb of the rat kidney.
1995,
Pubmed
Wang,
Developmental changes in the delayed rectifier K+ channels in mouse heart.
1996,
Pubmed
Welling,
A comprehensive guide to the ROMK potassium channel: form and function in health and disease.
2009,
Pubmed
Witchel,
Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes.
2002,
Pubmed
,
Xenbase
Yu,
Endogenous voltage-gated potassium channels in human embryonic kidney (HEK293) cells.
1998,
Pubmed
Zhou,
Primary structure and functional properties of an epithelial K channel.
1994,
Pubmed
,
Xenbase
